Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

Sinogel and Chondroitin: Effective Non-Surgical Options for Joint Health

Introduction

Living with joint pain or degeneration can be tough, and the thought of surgery is daunting for many. Thankfully, there are gentle, non-surgical solutions that can help — like Sinogel and chondroitin. Sinogel is a gel designed to restore the natural lubrication inside your joints, making movement smoother and more comfortable. Chondroitin, a natural component of cartilage, supports joint health and helps fight inflammation. Used together, these treatments offer promising alternatives to surgery, especially for adults who want to stay active without undergoing invasive procedures. Recent research shows that non-surgical options like Sinogel and chondroitin can be effective in managing mild to moderate joint problems, offering hope to those looking for relief without the risks and downtime of surgery.

Who Can Benefit from Sinogel and Chondroitin?

These treatments are especially helpful for adults who are experiencing joint pain from everyday wear and tear or recovering from joint injuries. The knees and hips, which support much of our body weight, are often most affected by conditions like osteoarthritis — a gradual wearing away of the joint’s protective cartilage. If you’re struggling with reduced mobility, stiffness, or pain due to such changes, Sinogel and chondroitin may provide much-needed relief. They’re also a great option for those who want to avoid surgery or aren’t good candidates for it due to other health concerns. Not everyone who undergoes joint replacement surgery is happy with the outcome, with some experiencing persistent pain even after the procedure. For many, non-surgical treatments can offer significant improvement and may even delay or prevent the need for surgery. Doctors always consider individual factors like age, lifestyle, and the severity of joint issues to create a treatment plan tailored to you. However, it’s important to note that access to these treatments may differ based on age, geographic location, and overall health — highlighting the need for more accessible joint care for everyone.

Which Joints Respond Best?

While Sinogel and chondroitin can benefit several joints, the knees and hips tend to see the greatest improvements. These large, weight-bearing joints are prone to damage from daily activities and the natural aging process. Sinogel acts by improving the quality of synovial fluid — the joint’s natural lubricant — to reduce friction and support easier movement. Chondroitin helps rebuild and maintain healthy cartilage, while also easing inflammation that causes pain and stiffness. Clinical studies show that these therapies can slow down joint damage and improve day-to-day function, especially in the knees and hips. Real-world research also points out that only a small percentage of eligible patients receive timely surgery, due to access challenges. This makes effective, non-surgical options even more important for adults looking to maintain their mobility and quality of life.

How Do Non-Surgical Treatments Compare to Surgery?

Surgery, such as joint replacement, is sometimes necessary — but it can mean long recovery times, higher costs, and inherent risks. In contrast, Sinogel injections and chondroitin supplements generally have fewer side effects and allow people to get back to normal life more quickly. Their effectiveness depends on factors like a person’s age, how much the joint has deteriorated, and any previous injuries. For many people with mild to moderate joint problems, these non-invasive treatments can deliver significant relief, often postponing or reducing the need for surgery altogether. The best results come from personalised care, with healthcare professionals working closely with patients to develop plans that match their unique needs and circumstances.

Conclusion

Sinogel and chondroitin offer effective, non-surgical ways to manage joint pain and slow degeneration, particularly in crucial joints like the knees and hips. By restoring joint lubrication, supporting cartilage repair , and reducing inflammation, these therapies can improve comfort and mobility for many adults. Backed by growing scientific research, they give patients hope for an active, pain-free life without facing the challenges of surgery. As more people discover these options, and as access improves, Sinogel and chondroitin will become even more valuable tools in the quest for better joint health.

References

  • Dieppe, P., Lim, K., & Lohmander, S. (2011). Who should have knee joint replacement surgery for osteoarthritis? International Journal of Rheumatic Diseases, 14(2), 175-180.
  • Tampere, T., Arnout, N., & Victor, J. (2024). Total knee arthroplasty: The need for better patient selection. Knee Surgery Sports Traumatology Arthroscopy, 33(3), 784-788. https://doi.org/10.1002/ksa.12514
  • Yong, P. (2004). Inequalities in access to knee joint replacements for people in need. Annals of the Rheumatic Diseases, 63(11), 1483-1489. https://doi.org/10.1136/ard.2003.013938

Navigating ICD-10 Nuances in Primary Osteoarthritis of the Left Knee: A Clinical and Research Perspective

This article explores the importance of accurate ICD-10 coding for primary osteoarthritis of the left knee, highlighting its role in precise diagnosis, treatment planning, and research. It discusses challenges in distinguishing primary from secondary osteoarthritis, the impact of coding errors on patient care and data integrity, and the need for ongoing clinician education. Accurate coding enhances treatment effectiveness, aids fall prevention, and supports the development of personalized therapies. Advances in imaging, patient-reported outcomes, and upcoming ICD-11 updates promise improved disease tracking and management, ultimately improving patient outcomes and healthcare efficiency.

Read More »

Targeted Relief for Meniscus-Deficient Knees: How Arthrosamid® Helps Ease Post-Meniscectomy Osteoarthritis Symptoms

Arthrosamid® is a novel single-injection polyacrylamide hydrogel designed to relieve post-meniscectomy osteoarthritis knee pain by cushioning and stabilizing the joint. Unlike traditional treatments providing temporary relief, Arthrosamid® integrates into the synovial membrane, reducing bone-on-bone contact and enhancing knee function. Clinical studies show significant pain reduction and improved mobility lasting up to two years, especially in patients under 70 with moderate OA and normal BMI. The treatment is minimally invasive, well-tolerated, and may delay or prevent the need for surgery. Arthrosamid® offers a promising alternative to hyaluronic acid injections with longer-lasting effects, marking a breakthrough in managing post-meniscectomy knee osteoarthritis.

Read More »